Skip to main content
. Author manuscript; available in PMC: 2015 Sep 10.
Published in final edited form as: Dig Dis Sci. 2014 Feb 7;59(4):886–891. doi: 10.1007/s10620-014-3038-1

Fig. 1.

Fig. 1

Survival over time in all patients with end stage liver disease (ESLD). There was a survival advantage for the large LV/IBW group in all 323 patients with ESLD (X2 = 5.27, p = 0.022)